Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma

We treated 26 eyes of 25 young patients having a mean age of 30 years with intravitreal vascular endothelial growth factor (VEGF) inhibitor for choroidal new vessel (CNV) formation overlying choroidal osteoma over a mean follow-up of 26 months. Mean number of injections was 2.4 at 6 months, 3.2 at 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansour, Ahmad M., Arevalo, J. Fernando, Al Kahtani, Eman, Zegarra, Hernando, Abboud, Emad, Anand, Rajiv, Ahmadieh, Hamid, Sisk, Robert A., Mirza, Salman, Tuncer, Samuray, Navea Tejerina, Amparo, Mataix, Jorge, Ascaso, Francisco J., Pulido, Jose S., Guthoff, Rainer, Goebel, Winfried, Roh, Young Jung, Banker, Alay S., Gentile, Ronald C., Martinez, Isabel Alonso, Morris, Rodney, Panday, Neeraj, Min, Park Jung, Mercé, Emilie, Lai, Timothy Y. Y., Massoud, Vicky, Ghazi, Nicola G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132478/
https://www.ncbi.nlm.nih.gov/pubmed/25147732
http://dx.doi.org/10.1155/2014/210458

Ejemplares similares

Ejemplares similares